Literature DB >> 16103757

Treating stage 2 hypertension.

Thomas D Giles1, Barry J Materson.   

Abstract

The prevalence of hypertension increases with advancing age, due primarily to increases in systolic blood pressure. Systolic hypertension is the most common form of hypertension in individuals over 50 years of age and reflects pathologic decreases in arterial compliance. Systolic blood pressure elevation is a more important risk factor for cardiovascular disease than is diastolic blood pressure elevation. Stage 2 hypertension, defined as blood pressure > or =160/100 mm Hg, is often found in older persons, who are at highest risk for cardiovascular events. In this clinical review, hypertension experts utilize a case study to provide a paradigm for treating older patients with stage 2 hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103757      PMCID: PMC8109319          DOI: 10.1111/j.1524-6175.2005.04535.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

Review 1.  Fixed low-dose drug combination for the treatment of hypertension.

Authors:  S G Chrysant
Journal:  Arch Fam Med       Date:  1998 Jul-Aug

2.  Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.

Authors:  R Guthrie; D R Reggi; M M Plesher; R K Saini; J P Battikha
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

3.  Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients.

Authors:  M H Weinberger
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

Review 4.  Impact of age, race, and obesity on hypertensive mechanisms and therapy.

Authors:  M R Weir
Journal:  Am J Med       Date:  1991-05-17       Impact factor: 4.965

5.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

6.  The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

Authors:  Larry E Fields; Vicki L Burt; Jeffery A Cutler; Jeffrey Hughes; Edward J Roccella; Paul Sorlie
Journal:  Hypertension       Date:  2004-08-23       Impact factor: 10.190

7.  Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.

Authors:  Nicholas L M Cruden; Fraser N Witherow; David J Webb; Keith A A Fox; David E Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-22       Impact factor: 8.311

8.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination.

Authors:  P H Vlasses; H H Rotmensch; B N Swanson; J D Irvin; R B Lee; J R Koplin; R K Ferguson
Journal:  J Clin Pharmacol       Date:  1983 May-Jun       Impact factor: 3.126

10.  Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization.

Authors:  Mark Alexander; Nancy P Gordon; Catherine C Davis; Roland S Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more
  1 in total

1.  The influence of locus control on adherence to treatment regimen among hypertensive patients.

Authors:  Obiageli Omeje; Chinenye Nebo
Journal:  Patient Prefer Adherence       Date:  2011-04-20       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.